Discover how targeted NGS is reshaping precision oncology—get your free expert guide

Delays in diagnosis. Limited insights. Rising complexity in myeloid malignancies. Traditional single-gene testing no longer keeps pace with the demands of modern hematology-oncology.

In this free in-depth resource from Thermo Fisher Scientific, explore how next-generation sequencing (NGS) is transforming molecular diagnostics for disorders like AML, MDS, CML, and more. This PDF guide outlines:

• The clinical need for rapid, in-house NGS testing
• How targeted NGS panels improve diagnostic speed and accuracy
• The benefits of streamlined workflows and integrated bioinformatics
• Expert opinions on risk stratification, therapy selection, and MRD detection

Whether you’re a pathologist, lab director, or oncology specialist, this guide will help you navigate the future of precision medicine and elevate patient care.